Takara Bio Report2019 December 23, 2019December 24, 2019 by / Share This.....LinkedinTwitterFacebookGoogleEmail About Us Message from the president Corporate Data and Subsidiaries Corporate Executives Directions to Takara Bio Quality Assurance Policy Consolidated Subsidiaries Business Outline Bioindustry Gene Therapy News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline News Release Investor Relstions Japanese Products Site サブ-ナビゲーション Top Management Policy Message from the President Formulation of Medium-Term Management Plan FY2020 Corporate Governance Business Risks Financial Data Financial Highlights Financial Indicators Cash Flow Business Segments IR Library Financial Results Presentation Materials Annual Report Stock Information General Meeting of Shareholders Shareholder Return / Dividends Stock Overview Stock Status Stock Price IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide 2019/12/24 Related News: [Delayed]Takara Bio Announces Transfer of SAKIGAKE…Takara Bio Group Formulated “Medium-Term Management…Takara Bio Report 2022Takara Bio Report 2023Using Biotechnology and Digital Technology to…PerkinElmer Showcases Leading Informatics Solutions…
